Open Access Green as soon as Postprint is submitted to ZB.
		
    A cost-utility analysis of increasing percutaneous coronary intervention use in elderly patients with acute coronary syndromes in six European countries.
        
        Eur. J. Prev. Cardiol. 28, 408-417 (2021)
    
    
    
	    Aims Percutaneous coronary intervention reduces mortality in acute coronary syndrome patients but the cost-utility of increasing its use in elderly acute coronary syndrome patients is unknown. Methods We assessed the efficiency of increased percutaneous coronary intervention use compared to current practice in patients aged >= 75 years admitted for acute coronary syndrome in France, Germany, Greece, Italy, Portugal and Spain with a semi-Markov state transition model. In-hospital mortality reduction estimates by percutaneous coronary intervention use and costs were derived from the EUROpean Treatment & Reduction of Acute Coronary Syndromes cost analysis EU project (n = 28,600). Risk of recurrence and out-of-hospital all-cause mortality were obtained from the Information System for the Development of Research in Primary Care (SIDIAP) database from North-Eastern Spain (n = 55,564). In-hospital mortality was modelled using stratified propensity score analysis. The 8-year acute coronary syndrome recurrence risk and out-of-hospital mortality were estimated with a multistate survival model. The scenarios analysed were to increase percutaneous coronary intervention use among patients with the highest, moderate and lowest probability of receiving percutaneous coronary intervention based on the propensity score analysis. Results France, Greece and Portugal showed similar total costs/1000 individuals (7.29-11.05 m euro); while in Germany, Italy and Spain, costs were higher (13.53-22.57 m euro). Incremental cost-utility ratios of providing percutaneous coronary intervention to all patients ranged from 2262.8 euro/quality adjusted life year gained for German males to 6324.3 euro/quality adjusted life year gained for Italian females. Increasing percutaneous coronary intervention use was cost-effective at a willingness-to-pay threshold of 10,000 euro/quality adjusted life year gained for all scenarios in the six countries, in males and females. Conclusion Compared to current clinical practice, broadening percutaneous coronary intervention use in elderly acute coronary syndrome patients would be cost-effective across different healthcare systems in Europe, regardless of the selected strategy.
	
	
      Impact Factor
		Scopus SNIP
		Web of Science
Times Cited
		Times Cited
Scopus
Cited By
		Cited By
Altmetric
		
	    7.804
		1.889
		1
		4
		
	    Annotations
	    
		
		     
		    
		
	    
	
		
	
	    Special Publikation
	    
		
		     
		
	    
	
	
	
	    Hide on homepage
	    
		
		     
		
	    
	
	
        Publication type
        Article: Journal article
    
 
    
        Document type
        Scientific Article
    
 
     
    
    
        Keywords
        Elderly ; Acute Coronary Syndrome ; Percutaneous Coronary Intervention ; Cost-effectiveness ; Cost-utility; St-segment Elevation; Cardiovascular Events; Myocardial-infarction; Invasive Strategy; Artery-disease; Primary-care; 2017 Esc; Management; Outcomes; Stroke
    
 
     
    
    
        Language
        english
    
 
    
        Publication Year
        2021
    
 
    
        Prepublished in Year
        2020
    
 
    
        HGF-reported in Year
        2020
    
 
    
    
        ISSN (print) / ISBN
        2047-4873
    
 
    
        e-ISSN
        2047-4881
    
 
    
     
     
	     
	 
	 
     
	
    
        Quellenangaben
        
	    Volume: 28,  
	    Issue: 4,  
	    Pages: 408-417 
	    
	    
	
    
 
    
         
        
            Publisher
            Sage
        
 
        
            Publishing Place
            1 Olivers Yard, 55 City Road, London Ec1y 1sp, England
        
 
	
         
         
         
         
         
	
         
         
         
    
         
         
         
         
         
         
         
    
        Reviewing status
        Peer reviewed
    
 
     
    
        POF-Topic(s)
        30202 - Environmental Health
    
 
    
        Research field(s)
        Genetics and Epidemiology
    
 
    
        PSP Element(s)
        G-502900-001
    
 
     
     	
    
    
        WOS ID
        WOS:000551150500001
    
    
        Scopus ID
        85088313033
    
    
        PubMed ID
        33966078
    
    
        PubMed ID
        32689836
    
    
        Erfassungsdatum
        2020-09-30